文献速递脊柱关节炎类风湿关节炎

非甾体抗炎药与心血管风险——适应证是关键

Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication.
PubMed 文献 · Semin Arthritis Rheum · 2019-08-01

本文讨论非甾体抗炎药(NSAIDs)在炎症性疾病(如强直性脊柱炎和类风湿关节炎)与非炎症性疾病中心血管效应的差异。近期两项大型独立研究显示,强直性脊柱炎患者中与死亡率相关的是低而非高NSAIDs摄入,类风湿关节炎也有类似数据,提示适应证影响NSAIDs的心血管风险。

要点

  • NSAIDs是强直性脊柱炎一线治疗,也常用于类风湿关节炎,但心血管事件风险受关注。
  • 两项大型独立研究中,强直性脊柱炎患者低而非高NSAIDs摄入与死亡率相关。
  • 类风湿关节炎有类似数据,提示适应证(炎症 vs 非炎症)影响心血管效应。

核心结论

  • NSAIDs的心血管效应受适应证(炎症性疾病 vs 非炎症性疾病)的重要影响。
  • 在强直性脊柱炎和类风湿关节炎中,观察数据不支持NSAIDs普遍增加心血管死亡率。

研究设计与样本

  • 本文为讨论性文章,基于近期两项大型独立研究及类风湿关节炎类似数据。

主要发现

  • 两项大型独立研究中,强直性脊柱炎患者中与死亡率相关的是低而非高NSAIDs摄入。
  • 类风湿关节炎存在类似数据。
  • 上述观察与NSAIDs普遍增加心血管死亡率不一致。

临床怎么用

  • 处方NSAIDs时应考虑适应证(炎症性疾病 vs 非炎症性疾病)对心血管风险的影响。
  • 在强直性脊柱炎和类风湿关节炎中,不应仅因心血管风险顾虑而普遍限制NSAIDs使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The term non-steroidal anti-inflammatory drugs (NSAIDs) covers a heterogeneous group of compounds that possess analgesic, antipyretic and anti-inflammatory properties. NSAIDs are recommended as first-line therapy in patients with ankylosing spondylitis (AS) and are also frequently used in rheumatoid arthritis (RA). However, adverse reactions are relatively common, including an increased risk for cardiovascular events which has remained a concern for both, patients and physicians, and the United States Food and Drug Administration (FDA) has recently expressed a straight forward warning in this regard. Recent data on the use of NSAIDs in inflammatory diseases are now challenging this hypothesis. In two large independent studies, it was not the high but the low intake of NSAIDs that was associated with mortality in AS patients. Analogous data exist for RA. This observation is obviously not consistent with a general increase of cardiovascular mortality due to NSAIDs. Here we discuss the important impact of indication (inflammatory vs. non-inflammatory diseases) on the cardiovascular effects of NSAIDs, including traditional NSAIDs (t-NSAIDS) and coxibs.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Braun J, Baraliakos X, Westhoff T, et al. Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication. Semin Arthritis Rheum. 2019. PMID: 31439354. doi:10.1016/j.semarthrit.2019.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。